|
Volume 271, Number 29,
Issue of July 19, 1996
pp. 17536-17546
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
The Pem Homeobox Gene
ANDROGEN-DEPENDENT AND -INDEPENDENT PROMOTERS AND
TISSUE-SPECIFIC ALTERNATIVE RNA SPLICING*
(Received for publication, March 22, 1996)
Sourindra
Maiti
,
Jessica
Doskow
,
Shulin
Li
,
Ron P.
Nhim
,
J.
Suzanne
Lindsey
and
Miles F.
Wilkinson
§
From the Department of Immunology, University of Texas, M.D.
Anderson Cancer Center, Houston, Texas 77030 and the
Molecular Microbiology and Immunology Department, Oregon
Health Sciences University, Portland, Oregon 97201
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
FOOTNOTES
Acknowledgments
REFERENCES
ABSTRACT
The Pem gene encodes an atypical
homeodomain protein, distantly related to Prd/Pax family
members, that we demonstrate is regulated in a complex transcriptional
and post-transcriptional manner. We show that the rat Pem
genomic structure includes three 5 -untranslated (5 -UT) exons
and four coding exons, three of which encode the homeodomain. Several
alternatively spliced transcripts were identified, including one that
skips an internal coding exon, enabling this mRNA to express a
novel form of the Pem protein. Other alternatively spliced mRNAs
were characterized that possess different 5 -UT regions, including a
muscle-specific transcript. The different 5 -UT termini present in
Pem transcripts conferred different levels of
translatability in vitro. Two promoters containing multiple
transcription initiation sites were identified: a distal promoter
(Pd) in the first 5 -UT exon and a proximal promoter
(Pp) located in the ``intron'' upstream of the first
coding exon. The Pd was active in placenta, ovary, tumor
cell lines, and to a lesser extent in skeletal muscle. In contrast,
transcripts from the Pp were only detectable in testis and
epididymis and were only expressed in epididymis in the presence of
testosterone. To our knowledge no transcription factors have previously
been identified that exhibit androgen-dependent expression
in the epididymis.
INTRODUCTION
Androgens are of paramount importance to spermatogenesis in the
testis and sperm maturation in the epididymis. Testosterone alone
maintains spermatogenesis in gonadotropin-deficient animals, including
hypophysectomized rats and mutant hypogonadal mice (1, 2, 3).
Evidence suggests that testosterone drives spermatogenesis by acting on
Sertoli cells and peritubular cells, both of which express androgen
receptors (4, 5). Sertoli cells perform numerous functions critical for
spermatogenesis by virtue of their intimate contact with
differentiating germ cells within the seminiferous tubule. Androgens
have been known to be critical for epididymal function since early in
this century. They regulate the proliferation and differentiation of
somatic cells in the epididymis and control the microenvironment of the
maturing spermatozoa by regulating the synthesis of adhesion proteins
in the epididymis, the secretion of proteins into the luminal fluid
that are in contact with the spermatozoa, and the transport of ions and
small organic molecules across the epididymal epithelium (6, 7).
Secreted proteins under androgen control in the epididymis include
steroid-metabolizing enzymes, polyamine synthesis enzymes,
detoxification enzymes, oxidation reduction enzymes, hydrolases,
and proteases (6, 7, 8).
The transcription factors that orchestrate
androgen-dependent events in the testis and epididymis have
not been identified, although the androgen receptor clearly plays a
major role in such responses. Homeobox transcription factors are
candidates to regulate spermatogenesis and sperm maturation, since they
are known to regulate many other developmental events. The
distinguishing feature of homeobox proteins is a conserved DNA-binding
motif 60 amino acids in length, termed a homeodomain. The homeodomain
is comprised of three -helices; sequence specificity is conferred by
key residues in the third helix that direct binding to base contacts in
the major groove of DNA. The best understood homeobox proteins are
those encoded by the hox/hom, prd/pax, and
POU gene families (9). Studies in Drosophila
melanogaster, Xenopus laevis, and mice have shown that
members of these classical homeobox gene families are required for
discrete events during development. For example, studies in null mutant
mice have demonstrated that the Pax-6 gene activates a
regulatory cascade necessary for eye development (10), the Oct-2
POU homeobox gene promotes late stages of B-cell maturation (11),
and Hox genes specify axial identity during embryogenesis
(12).
Homeobox transcription factor genes have been shown to be expressed in
the male reproductive system, but none have been shown to be
androgen-regulated. Many of these homeobox genes are expressed in germ
cells of the testis. For example, the POU homeobox gene
sperm-1 is expressed transiently prior to meiosis in germ
cells (13), and Hoxa-4 is expressed specifically in
postmeiotic germ cells (14, 15). Hoxb-4 is expressed by both
germ cells and somatic cells in the testis, while Hoxd-4 is
expressed by Leydig cells (15). Both Hoxb-4 and
Hoxd-4 are expressed by other adult organs besides testis
(16, 17). Little is known about the expression pattern of transcription
factors in the epididymis. To our knowledge the only transcription
factor genes identified as expressed in the epididymis are the homeobox
gene Pax-2 (18) and the ETS-like transcription factor
PEA3 (19).
In a search for developmentally regulated genes, we used the
subtraction hybridization technique to isolate several cDNAs
corresponding to novel genes (20), including the homeobox gene,
Pem (21, 22). The Pem homeodomain shares modest
sequence identity with prd/pax homeodomains (22, 23), but
its primary amino acid sequence is sufficiently unique to warrant
classification in a different subfamily. The Pem gene is
expressed in a unique pattern during embryogenesis. Tissues that
contribute to the extraembryonic compartment express mouse
Pem; the gene remains highly expressed in the placenta and
yolk sac until term (21, 24). The in vivo expression pattern
of Pem in endodermal tissue is mimicked in pluripotent stem
cell lines that differentiate in vitro; F9 embryonal
carcinoma stem cells induced to differentiate into either the visceral
or endodermal lineage up-regulate Pem mRNA expression
(22) and accumulate Pem protein specifically in the outer layer of
cells that possess characteristics of extraembryonic endoderm (24, 25).
Pem gene expression is also dramatically up-regulated in
normal diploid embryonic stem cells induced to differentiate in
vitro (22), although it is not known which specific differentiated
cell types activate Pem gene expression.
In this communication, we report that Pem gene expression is
not restricted to embryogenesis. We show that in prepubertal and adult
rats, the Pem gene is specifically transcribed in both male
and female reproductive tissue and to a lesser extent in skeletal
muscle. Transcript analyses revealed that Pem transcripts
are derived from two promoters and undergo complex alternative splicing
events that are regulated in a tissue-specific manner. The alternative
splicing events alter both the 5 -UT1 and
coding regions of Pem mRNA. We demonstrate
androgen-dependent expression of Pem transcripts
from the promoter used exclusively by male reproductive tissue. The
complex and androgen-dependent pattern of Pem
expression by alternative promoter usage and alternative splicing has
important implications for the possible role of the Pem
homeobox gene in development.
MATERIALS AND METHODS
Isolation and Characterization of Rat Pem cDNA and Genomic
Clones
To obtain rat Pem cDNA clones, a mouse
Pem cDNA probe was used to screen 5 × 105 plaques (26) from a Rat-1 fibroblast cDNA library
in ZAP (kindly provided by David Pribnow). Southern blot analysis
revealed that 31 independent Rat-1 cDNA clones contained inserts
that strongly hybridized with the mouse Pem probe. Many of
the cDNA clones were sequenced at their 5 termini to determine the
approximate site of transcriptional initiation (see ``Results''). DNA
sequence analysis was performed by the dideoxy method according to the
manufacturer's instructions (U.S. Biochemical Corp.).
Three genomic libraries and a P1 rat genomic library were screened
to obtain rat Pem genomic clones that correspond to the rat
Pem cDNAs that we had isolated. We were not able to
isolate any clones for a functional rat Pem gene, but
instead isolated several independent copies of a rat Pem
pseudogene, and thus we concluded that sequences within or near the
functional rat Pem gene might interfere with proportional
representation in genomic libraries. Thus, we used the ``long PCR''
approach as an alternative strategy to obtain rat Pem
genomic clones. PCR was performed with rat genomic DNA as a template
for 35 cycles with the XL-PCR kit according to the manufacturer's
instructions (Perkin-Elmer) under the following conditions for each
segment: 94 °C for 1 min, 52 °C for 2 min, and 68 °C for 7 min. Oligonucleotides (oligos) corresponding to middle (primer A) and
3 (primer B) portions of the rat Pem cDNA were used for
PCR amplification (see Fig. 1 for location of primers). A 3.5-kilobase
fragment was amplified, subcloned, and sequenced. The exon sequences in
clone 1 were identical to the sequences present in the rat
Pem cDNA clones. Next, primers corresponding to 5
(oligo C) and middle (oligo D) cDNA sequences were used for long
PCR amplification. Sequence analysis of the resulting fragment (clone
2) revealed that it overlapped clone 1 by 57 nucleotides, as expected.
Together, clones 1 and 2 comprised the entire rat Pem coding
region and all intervening introns.
Fig. 1.
Rat Pem genomic sequence.
Coding regions are shown in uppercase boldface letters;
intron sequences are in lowercase lightface letters (only
the intron/exon junctions for IVS1 are shown). The names of the exons
are indicated on the left (the M exon is a muscle-specific
exon). Nucleotide positions relative to the ATG start codon are
provided on the right. The approximate locations of the
transcription initiation sites within the Pd and
Pp are boxed. The alternative splice junctions
in IVS1 and IVS2 used to generate transcripts B and C, respectively
(Fig. 2), are indicated by arrows. The locations of the
complementary oligonucleotides used in this study are
underlined, and their name and orientation are shown on the
right. The positions of the oligonucleotides are as follows:
A, 332-351; B, 3885-3864; C, 676 to 658; D, 387-371; E, 3 to
18; F, 646 to 666; G, 662 to 682; H, 17 to 3; I, 3880-3859;
J, comprises the 3 terminus of exon 1 (18 nt) and the 5 terminus of
exon 2 (3 nt); K, 114 to 94; L, 3884-3905.
The genomic organization of rat Pem was confirmed by
analysis of two other subcloned PCR products (clones 3 and 4) derived
from other primer sets. Clone 3 was generated using an oligonucleotide
that included the start codon ATG (oligo E) in combination with oligo
B. This 4-kilobase PCR product was subcloned and shown to possess
restriction sites predicted from sequence analysis of clones 1 and 2. Clone 4 was a 5 PCR product that was generated using an intron 1 oligo
(oligo F) that bound fortuitously to a region in the the third exon.
Sequence analysis of this 0.5-kilobase PCR product showed that it
contained the sequences predicted from clone 2.
To obtain sequences upstream of exon 2, we employed the method of
Siebert et al. (27). The ``Rat Promoter Finder Kit'' used
for this upstream walking (a generous gift from Clontech) was used
according to the manufacturer's instructions, except that the rTth DNA
polymerase XL (from Perkin-Elmer) was used in place of the enzyme
provided by this kit. The primary PCR was performed with primer AP1 and
oligo F for 7 cycles under the following cycle parameters: 94 °C for
5 s and 68 °C for 4 min. The secondary PCR was done with primer
AP2 and oligo G for 40 cycles under the following cycle parameters:
94 °C for 5 s and 63 °C for 4 min for 40 cycles. Sequence
analysis of the subcloned PCR product (clone 5) showed it contained an
intron (IVS1) and exon sequences (exons 1 and 2) identical to known rat
Pem cDNA sequences.
RNA Isolation and RNase Protection Analysis
Total RNA from
tissues was prepared as described previously by either guanidinium
isothiocyanate lysis and centrifugation over a cesium chloride cushion
(28) or by a single-step acid guanidinium thiocyanate/phenol/chloroform
extraction (29). For RNase protection analysis, we prepared
[32P]UTP-labeled RNA probes with T7, T3, or SP6 RNA
polymerase. The probes used for RNase protection analysis contained the
following exon and intron sequences: probe A, IVS2B (142 nt), E3 (82 nt), IVS3 (167 nt), E4 (~140 nt) = ~530 nt; probe B, E2 (30 nt),
IVS2-E3-IVS3 (complete), E4 (~140 nt) = ~1060 nt; probe C, IVS2B
(125 nt), E3 (82 nt), E4 (~140 nt) = ~350 nt; probe D, E1 (~30
nt), E2 (61 nt), E3 (82 nt), E4 (~140 nt) = ~310 nt; probe E, E1
(49 nt), E2 (61 nt), E3 (30 nt) = 140 nt; probe F, E1 (29 nt), E2 (61 nt), E3 (30 nt) = 120 nt; probe G, E1 (40 nt), M exon (45 nt), E2 (61 nt), E3 (82 nt), E4 (~140 nt) = ~370 nt; probe H, E1 (18 nt), IVS1
(3 -terminal 38 nt), E2 (61 nt), E3 (72 nt) = 189 nt; probe I, E2 (56 nt), IVS2B (30 nt, ending 41 nt from the IVS2B/E3 border) = 86 nt;
probe J, E4 (69 nt), E5 (46 nt), E6 (220 nt) = 335 nt.
In some experiments, a glyceraldehyde-3-phosphate dehydrogenase probe
was included in the annealing reaction as a positive control. For probe
synthesis, we used the in vitro transcription protocol as
described (30). Probes were purified in a 8 M urea, 6%
polyacrylamide denaturing gel. After exposure to film, the
appropriately sized bands were excised from the gel and placed in
individual Eppendorf tubes. The gel slices were mashed with an
RNase-free pestle in 100 µl of diethylpyrocarbonate-treated water. To
each sample, 600 µl of proteinase K-containing solution (0.3 M NaCl, 0.5% SDS, 10 mM Tris (pH 7.5), 200 µg/ml proteinase K, and 20 µg/ml tRNA) was added, vortexed, and
incubated at 37 °C for 15 min. After vortexing and pulse-spin, the
suspended probe was filtered through a 0.45-µm filter (Acrodisc),
followed by passing 200 µl more proteinase K solution through the
filter to increase the recovery of probe. Each sample was then
extracted with 200 µl of phenol/chloroform. One microliter was used
to determine radioactive counts per minute, and the rest was
ethanol-precipitated and stored at 70 °C.
RNase protection analyses were performed as described (30), with minor
modifications. Briefly, sample RNA or tRNA (negative control) was
co-precipitated with the appropriate gel-purified
[32P]UTP-labeled probes. The pellet was resuspended in 30 µl of annealing buffer (40 mM PIPES (pH 6.4) 0.4 M NaCl, 1 mM EDTA, 80% formamide) and allowed
to hybridize overnight at 44 °C. Unhybridized RNA was digested with
RNase A and RNase T1 for 20 min at 37 °C at concentrations of 25 µg/ml and 5 µg/ml, respectively, unless otherwise noted. RNases
were then removed by treatment with proteinase K and extraction with
phenol/chloroform/isoamyl alcohol. After ethanol precipitation, the RNA
pellet was resuspended in 90% formamide loading buffer, denatured at
85 °C, electrophoresed in a 8 M urea, 6% polyacrylamide
gel. A set of RNA size markers generated from the Century ladder
template (Ambion) was included in all gels.
Primer Extension Analysis
Primer extension was carried out
essentially as described by McKnight et al. (31) using total
cellular RNA (30 µg) from rat placenta and
32P-end-labeled primers. The labeled oligo (2 ng) and the
RNA mixture were ethanol-precipitated and resuspended in a total volume
of 18 µl of water and incubated on ice for 5 min with intermittent
vortexing, followed by the addition of 2 µl of 10 × annealing
buffer (3 M NaCl, 0.4 M Tricine (pH 8.0) and 1 mM EDTA), brief vortexing, and incubation at 65 °C for
10 min. Following the annealing reaction, the tubes were transferred to
the temperature of the extension reaction (42, 46, or 52 °C). To
each tube the following was added: 4 µl of 10 × extension
buffer (1 M Tris [pH 8.3], 120 mM
MgCl2, 100 mM dithiothreitol), 0.8 µl of 25 mM dNTPs, 14 µl of double-distilled H2O, and
5 units of either avian myeloblastosis virus (for 42 °C) or Moloney
murine leukemia virus reverse transcriptase (for 46 and 52 °C).
After a 60-min extension reaction, the template RNA was degraded by
incubation with 1 µl of RNase A (stock 10 mg/ml) at 37 °C for
1 h. The sample was then precipitated by the addition of 132 µl
of stop mixture (2.5 M NH4OAC, 10 mM EDTA) and 500 µl of ethanol. The products were
separated by electrophoresis in an 8 M urea, 6%
polyacrylamide gel.
Reverse Transcriptase-PCR (RT-PCR) and 5 -Rapid Amplification of
cDNA Ends (5 -RACE)
RT-PCR was performed as described (32)
using total cellular RNA (1 µg) from adult rat epididymis and
skeletal muscle. 5 -RACE was performed according to the manufacturer's
instructions (Life Technologies, Inc.). In brief, cDNA was
generated using a primer complementary to a region within exon 4, the
cDNA was dC-tailed with terminal transferase, and then PCR was
performed using oligo D and an ``anchor primer'' complementary to the
C-tail.
In Vitro Transcription and Translation
Three 147C3-based
plasmids were prepared that contained precisely the same rat
Pem open reading frame preceded by the 5 -UT region in A-,
M-, and T-transcripts (Fig. 2). The length of the Pem 5 -UT
region in the A-, M-, and T-transcripts was 93 nt, 138 nt, and 109 nt,
respectively. The plasmids were linearized with HindIII, and
RNA was synthesized in vitro according to the
manufacturer's instructions (Promega Corp.). The RNA was translated
in vitro using [35S]methionine and
reticulocyte lysates in a 25-µl reaction for 1 h at 30 °C
according to the manufacturer's instructions (Promega), and the
products were analyzed by SDS-polyacrylamide gel electrophoresis.
Fig. 2.
The rat Pem gene: two promoters
and alternative RNA splicing. The exon/intron structure is based
on the sequence analysis from Fig. 1. The names of the alternative
transcripts are indicated on the left. The names of tissues
and cell lines that express each transcript are provided on the
right. Note that T- and M-transcripts are expressed
specifically in the tissues indicated. In contrast, the other
transcripts may be expressed in additional cell types besides the ones
indicated.
Animals
Untreated, sham-operated, and hypophysectomized
Sprague-Dawley rats were obtained from Charles River Laboratories.
Animals were housed in the Oregon Health Sciences University animal
care facility and cared for according to approved protocols.
Hypophysectomized animals received 5% glucose water ad
libitum. Animals were killed by CO2 asphyxiation, and
organs were immediately removed, homogenized, and frozen at 70 °C
until RNA was extracted. The effectiveness of hypophysectomy was
determined by assessing testosterone levels in serum with a standard
chromatographic procedure (33). For the testosterone implant
experiments, hypophysectomized rats (12 days post-treatment) were
anesthetized at one atmosphere isofluorane and the implants (silastic
tubing 3 cm long filled with testosterone proprionate) were placed
subcutaneously along the upper back and neck in collaboration with Dr.
John Resko (Oregon Health Sciences University), who has shown that
these implants generate a serum concentration of 4 ng/ml testosterone.
The levels of testosterone and dihydrotestosterone (DHT) were
determined in contralateral epididymides (weighed, homogenized in
phosphate-buffered saline, and frozen at 70 °C until analysis).
The sham-operated animals had >6 pg of DHT/mg of tissue,
hypophysectomized animals had 1 pg of DHT/mg of tissue, and all
testosterone-treated animals had 3-4 pg of DHT/mg of tissue (assayed
2-8 days after introduction of the implants). All androgen assays were
done in the laboratory of Dr. David Hess at the Oregon Regional Primate
Research Center (Beaverton, OR).
RESULTS
The Pem Gene
As described under ``Materials and Methods,''
use of the long PCR method permitted isolation of several overlapping
DNA fragments that corresponded to the entire rat Pem gene.
Sequence analysis and comparison of these sequences with the known
mouse and rat Pem cDNA sequences (Ref. 22 and see below)
allowed us to deduce the genomic organization of the Pem
gene (Figs. 1 and 2). The exon/intron
splice junctions in the Pem gene conform to the consensus
sequences for 5 (CAG RAGT) and 3
(YnNY ) splice sites (the invariant dinucleotides
at the termini of the intron consensus sequences are underlined). The
homeodomain region of the Pem gene is interrupted by two
introns, positioned precisely in the same location as in the D. melanogaster prd class homeobox gene aristaless
(al) (34). The location of the second intron interrupting
the Pem homeodomain (IVS5) is identical to the location of
the intron in the homeodomain region of several other
prd/pax class homeobox genes, including the gsc,
S8, otx, unc-4, ceh-8, and
ceh-10 genes, but is in a different position than the
introns in most other known homeobox genes (9). This provides further
support that the Pem gene is a distant relative of the
Prd/Pax homeobox gene sub-family. We previously showed
that the Pem homeodomain exhibits up to 35% sequence
identity with prd/pax family member homeodomains (35).
In the studies described below, we demonstrate the usage of two
promoter regions in the Pem gene and show that transcripts
derived from these promoters undergo alternative splicing events. Fig.
2 summarizes the results of these studies. Below, we will first provide
evidence for the existence of the proximal promoter (Pp)
and then show its androgen-dependent regulation and
developmental expression pattern in male reproductive tissue. Then we
will define and analyze the distal promoter (Pd), which is
primarily expressed in ovary and placenta, and to a lesser extent in
male reproductive tissue and skeletal muscle. Throughout the analysis,
we also make use of two cell lines that transcribe the Pem
gene from the Pd: the Rat-1 immortalized fibroblast cell
line and the MCA8994 rat hepatoma cell line. We previously showed that
immortalized and tumor cell lines from multiple cell lineages express
the Pem gene (21).
A Proximal Promoter Active in Epididymis and
Testis
Pem transcripts derived from the Pp
were first identified from epididymis RNA by the PCR-based approach
5 -RACE. Sequencing of subcloned 5 -RACE products revealed that the 5
termini extended to several sites within the intron upstream of exon 3 (positions 59, 86, 94, 117, and 125 nt in Fig. 1). The
different lengths of these termini could be due to multiple
transcription start sites within the Pp, or they could have
resulted from incomplete cDNA synthesis by reverse
transcriptase.
RNase protection analysis was employed to determine whether multiple
transcription start sites were present in the Pp. Fig.
3 shows the results with probe A, which contains the
Pp region. Epididymis RNA protected four major fragments
(bands 1-4) that correspond to transcriptional initiation sites at the
following approximate positions relative to the initiator ATG: 126,
109, 75, and 68. Different ribonuclease A and T1
concentrations (over a 4-fold range) did not affect the migration of
bands 1-4 (data not shown), so these multiple bands do not represent
partial ribonuclease cleavage fragments, and instead correspond to
multiple sites of transcriptional initiation. Use of multiple
transcriptional initiation sites is typical for mammalian promoters
that lack an upstream TATA box, and indeed, no TATA box is present
upstream of the initiation sites in the Pp (Fig. 1). In
order to determine if any other transcription start sites are used in
epididymis further upstream within the intron, we also used a probe
that contained all of intron 2 (probe B). No additional bands were
obtained with this probe (data not shown), indicating that there are no
other transcription start sites within the Pp.
Fig. 3.
A proximal promoter (Pp)
expressed in epididymis. A, schematic diagram showing the
region encompassed by probe A and the regions of the probe protected by
RNA from placenta and epididymis. B, RNase protection
analysis using probe A and total cellular RNA from epididymis (20 µg), placenta (5 µg), or tRNA (20 µg). Bands 1-5 are
approximately 137, 149, 156, 190, and 207 nt in length, respectively,
as assessed by comparison of their migration with an RNA ladder in two
independent gels. A band representing exon 3 (~80 nt) is not
observable in the section of gel shown.
The transcription initiation sites within the Pp that we
defined in epididymis were also used in testis (see below) but were not
active in placenta, ovary, skeletal muscle, or two immortalized cell
lines that express the Pem gene, Rat-1 and MCA8994. Instead,
these tissues and cell lines expressed Pd-derived
transcripts, and thus they protected band 5 after annealing with probe
A (Fig. 3B and data not shown). Placental RNA not only
protected band 5 but also a much less abundant fragment that was
slightly larger than band 1. The origin of this band is not known; it
does not appear to represent transcription from the Pp
region, since another probe that included the Pp region
(probe C) failed to detect Pp-derived transcripts in
placenta (data not shown).
The Proximal Promoter Is Androgen-dependent
Since
the functional competence of the epididymis depends on the presence of
androgens (6, 7, 8), we tested whether transcripts derived from the
Pp depended on testosterone for expression. A probe that
included the Pp region (probe C) was used for this analysis
(Fig. 4A). Hypophysectomy caused a
precipitous drop in the levels of Pp-derived transcripts
(Fig. 4, B and C, band 1 in lanes labeled
HPX), whereas animals that underwent sham treatment
maintained Pp-derived transcript expression in the
epididymis. Introduction of exogenous testosterone in hypophysectomized
animals restored expression of these transcripts (lanes labeled
HPX1+T and HPX2+T in Fig. 4C represent
two different animals). Testosterone induced expression from the
Pp after 2 days of treatment (Fig. 4C);
expression was maintained for at least 8 days in other animals tested
(data not shown). These mRNAs derived from the Pp were
designated ``T-transcripts'' (Fig. 2), since they are inducible by
testosterone.
Fig. 4.
Pem regulation in the epididymis:
androgen-dependent expression from the Pp.
A, schematic diagram showing the region encompassed by probe
C and the regions of the probe protected by RNA from different cellular
sources. B, RNase protection analysis using probe C and
total cellular RNA from MCA8994 cells (5 µg) or epididymides (20 µg) obtained from hypophysectomized and sham-treated rats as
described under ``Materials and Methods.'' The MCA8994 rat hepatoma
cell line, like Rat-1 cells, serves as a positive control for
Pd-derived transcripts (band 2); the origin of the
minor bands above and below band 2 are not known. Band 1 encompasses ~300- 350-nt fragments (derived from multiple
transcription start sites in the Pp) and band 2 is ~220
nt. C, RNase protection analysis performed as in panel
B except that a glyceraldehyde-3-phosphate dehydrogenase probe was
also included in each annealing reaction to show the amount of RNA
annealed and loaded.
Developmental Shift from the Distal Promoter to the
Testosterone-dependent Promoter
Testis accumulated three major
Pem mRNAs represented by bands 1, 2, and 3 in Fig.
5B. Band 1 corresponds to A-transcript,
derived from the Pd, the predominant transcript also
expressed by placenta, ovary, and muscle (Fig. 2, and see below). Band
2 represents an mRNA that also appears to be transcribed from the
Pd, but its size suggests that it may have undergone an
alternative splicing event between exons 1 and 2 (although other
explanations are possible). Band 3 represents T-transcripts derived
from the Pp.
Fig. 5.
Developmental regulation of Pp
and Pd usage in the testis. A, schematic diagram
showing the region encompassed by probe D and the regions of the probe
protected by the three transcripts expressed by testis. The
testis-specific transcript (middle mRNA shown) is predicted to be
generated by alternative splicing of the first intron (depicted by the
dotted line) based on the size of the protected band
(labeled 2), but this was not determined definitively.
B, RNase protection analyses using probe D and total
cellular RNA from epididymis (30 µg) or testis (20 µg) derived from
rats of the ages shown. Note that the autoradiographic exposure time
for the epididymis lane was 10 times shorter than for testis. When
exposed for an equal time, it was evident that the level of
Pd-derived transcripts (band 1) is similar in epididymis
and testis. Band 1 is ~300 nt, band 2 is ~270 nt, and band 3 is
~205 nt. C, schematic diagram showing the region
encompassed by probe C and the regions of the probe protected by
Pem transcripts in testis. D, RNase protection
analysis using probe C and total cellular RNA from Rat-1 cells (5 µg), epididymis (15 µg), testis (20 and 50 µg for left
and right panels, respectively), or tRNA (20 µg).
Epididymides and testes were derived from animals of the ages shown.
Band 1 encompasses ~300-350-nt fragments (derived from multiple
transcription start sites in the Pp) and band 2 is ~220
nt.
The ratio of transcripts derived from the Pp and
Pd varied at different developmental stages in the testis.
At early time points after birth (days 5-33), the predominant
transcripts were derived from the Pd (Fig. 5B,
bands 1 and 2). T-transcripts (band 3) became more prominent by day 44 and later accumulated to similar levels as Pd-derived
transcripts (days 78 and 104). The developmental shift observed with a
Pd probe was confirmed by analyses with a Pp
probe (compare the ratio of band 1 with band 2 on day 21 with day
78 (Fig. 5D)). Note that the epididymis expressed much
higher levels of T-transcripts than did the testis: even young animals
(23 and 30 days old) accumulated high levels of T-transcripts in
epididymis (Fig. 5D).
Multiple Transcription Initiation Sites Used by the Distal
Promoter
The sites of transcriptional initiation from the
Pd were analyzed by three different approaches: 1) sequence
analysis of the 5 termini of cDNA clones; 2) RNase protection
analysis; and 3) primer extension analysis. The Rat-1 fibroblast cell
line was chosen for cDNA library screening since it expresses high
levels of Pem transcripts, as do many other immortalized and
tumor cell lines (21). Examination of the 5 termini of 15 independent
Rat-1 Pem cDNA clones showed a range of termini that
were clustered in exon 1 (5-29 nt of exon 1 were included in these
cDNA clones).
RNase protection analysis was performed with a probe complementary with
this putative promoter region in exon 1 (probe E; Fig.
6A). This analysis was done with RNA from the
Rat-1 cell line and placental tissue, since they both express high
levels of Pem transcripts from the Pd. Fig.
6B shows that multiple bands were protected by RNA from the
Rat-1 cell line and placenta. The lengths of the major bands (labeled
1-5) correspond to transcription start sites at positions
between 40 and 18 relative to the exon 1/intron 1 border. The
multiple bands did not represent partial RNase cleavage, since
alteration of RNase A and T1 concentrations did not alter
any of the major bands, although two new bands appeared at higher RNase
concentrations (Fig. 6C). The existence of multiple
transcription initiation sites at these positions was also shown with
two other probes that include this putative promoter region (probes F
and G; see ``Materials and Methods''). Analyses with probes F and G
showed that ovary and testis contained Pem mRNA with the
same 5 termini as did placenta and Rat-1 cells (data not shown).
Fig. 6.
Multiple transcriptional initiation sites in
the distal promoter (Pd). A, schematic diagram
of the first three exons in mature Pem mRNA, the region
encompassed by the probe used for RNase protection analysis, and the
approximate location of transcription initiation sites. B,
RNase protection analysis of total cellular RNA (20 µg) or tRNA (20 µg) annealed with probe E (contains 49 nt of exon 1), followed by
incubation with RNase A (25 µg/ml) and RNase T1 (4 µg/ml) as described under ``Materials and Methods.'' The average
lengths of bands 1-5, as determined in three independent gels, were
110, 113, 119, 123, and 131 nt, respectively. C, as in
panel B except that 3 µg of placental RNA was annealed,
and the concentrations of RNase used were as shown. D,
primer extension analysis of total cellular placental RNA (30 µg)
using primer H. The nucleotide positions of the extension products
(relative to the exon 1/intron 1 border) were determined by their
migration relative to sequencing ladders in the adjacent lanes.
Extension reactions performed in parallel with tRNA gave no visible
products at these positions.
Primer extension analysis was performed to determine definitively
whether transcription initiated at several sites in exon 1, as
suggested by RNase protection analysis, or whether transcription
initiated from an exon further upstream than exon 1. Fig. 6D
shows that primer extension analysis with oligonucleotide H yielded
products that indicated transcription initiates at several sites
between 40 and 22 relative to the exon 1/intron 1 border. This is
in agreement with the transcription initiation sites predicted by RNase
protection analysis (bands 1-4). Similar results were obtained when
extension by reverse transcriptase was performed at 42, 46, or 52 °C
or when another oligo was used for the analysis (oligo G; data not
shown). We conclude that multiple transcription initiation sites span a
region of approximately 20 nt in exon 1 of the rat Pem gene.
These initiation sites are used in placenta, ovary, and testis,
resulting in the generation of Pem transcripts possessing 5
termini of slightly different lengths. No TATA box is present upstream
of the multiple start sites in the Pd (Fig. 1).
A 5 -UT Exon Uniquely Included in Skeletal Muscle
RNase
protection analysis revealed that the Pd was not only
transcriptionally active in reproductive tissue but also in skeletal
muscle. We examined the 5 termini of muscle Pem transcripts
by the 5 -RACE method. Sequence analysis of the subcloned 5 RACE
products from muscle showed that the 5 termini of these products was
in the Pd in exon 1. Surprisingly, two of the six subcloned
PCR products possessed a novel 45-nt sequence inserted in the 5 -UT
region between exons 1 and 2. This sequence corresponded to a 45-nt
sequence that we identified in genomic DNA between exons 1 and 2 that
is flanked by canonical 5 and 3 splice sites (Figs. 1 and 2). Thus,
this novel sequence is an alternatively spliced exon (termed the M
exon) that is included in Pem transcripts in skeletal muscle
(Fig. 2). The M exon possesses two initiator AUG codons (Fig. 1). The
first AUG is followed by a termination codon five codons downstream.
The second AUG is in-frame with the Pem protein reading frame and would
dictate a seven-amino acid N-terminal extension to the Pem protein.
However, the sequences surrounding both AUGs exhibit poor matches with
the Kozak consensus sequence GCCRCC G (36). They possess
neither the critically important purine at position 3 nor the G at
position +4.
To examine the regulation of M exon inclusion, a Pem probe
containing the M exon (probe G) was prepared for RNase protection
analysis (Fig. 7A). Fig. 7B shows
that skeletal muscle RNA protected two bands (1 and 2), which represent
M exon+ and M exon transcripts, respectively.
It is not known if the M exon+ transcripts are present in a
specific subpopulation of cells in muscle or if they are present in all
cell types in this tissue. No difference in the relative expression
levels of the M+ and M transcripts was noted
in skeletal muscle from male and female animals (Fig. 7B).
In contrast to skeletal muscle, we could not detect M+
transcripts in any other tissues or cell lines tested, including
placenta, epididymis, testis, ovary, and Rat-1 cells (Fig.
7B and data not shown). Thus, the inclusion of the M exon by
alternative splicing appears to be regulated in a tissue-specific
manner.
Fig. 7.
Alternative RNA splicing in the 5 -UT region.
A, schematic diagram showing the region encompassed by probe
G and the regions of the probe protected by RNA from different cellular
sources. B, RNase protection analysis using probe G and
total cellular RNA from skeletal muscle (40 µg), placenta (10 µg
for left panel, 3 µg for right panel), Rat-1
cells (10 µg), ovary (20 µg), or tRNA (20 µg). Band 1 is
~350-370 nt; band 2 is ~210 nt, and band 3 is ~90-105 nt. The
multiple protected fragments in bands 1 and 3 are due to multiple
transcription start sites. Note that longer autoradiographic exposures
are shown for the lanes with skeletal muscle RNA since Pem
expression is lower in this tissue. C, schematic diagram
showing the region encompassed by probe I and the regions of the probe
protected by the two spliced RNAs. D, RNase protection
analysis using probe I and total cellular RNA from placenta (5 µg),
Rat-1 cells (5 µg), or epididymis (20 µg). Band 1 is ~85 nt and
band 2 is ~60 nt.
Alternative Splicing of 5 -UT Exons in Placenta and Rat-1
Cells
Further Pem alternatively spliced mRNAs were
revealed from sequence analysis of Rat-1 cDNA clones. Although most
Rat-1 cDNA clones corresponded to A-transcript (Fig. 2), two of the
cDNA clones were derived from alternatively spliced mRNAs,
termed B- and C-transcripts (Fig. 2). B-transcript is derived by an
alternative splice acceptor in IVS1 (Fig. 1), which results in the
inclusion of 38 nt from IVS1. RNase protection analysis with a probe
prepared from this variant cDNA (probe H) showed that the
B-transcript was expressed at about 5-fold lower levels than the
A-transcript in placenta and the Rat-1 and MCA8994 cell lines (data not
shown). The C-transcript was derived by use of an alternative splice
acceptor in IVS2 (Fig. 1), resulting in the inclusion of 61 nt from
IVS2. RNase protection analysis showed that Rat-1 cells and placenta
expressed C-transcript (Fig. 7, C and D). The B-
and C transcripts encode the same Pem protein as the more abundant
A-transcript, since the inclusion of additional 5 -UT sequences in the
B- and C-transcripts did not introduce an initiator AUG
upstream of the initiator AUG in exon 3. The regulatory significance of
the alternative splice acceptors in IVS1 and IVS2 is not known.
An Exon-skipped Transcript Encodes a Novel
Protein
Transcripts that skip exon 4 ( E4 transcripts) were
revealed by sequence analysis of RT-PCR products generated from
epididymis RNA. These E4 transcripts originated from either the
Pp or the Pd, as shown by sequence analysis of
subcloned epididymal RT-PCR products generated using any of the
following oligo combinations: C + B, J + I, or K + L (Fig. 1). RNase
protection analysis with a probe that spanned exon 4 and the adjacent
exons (probe J; Fig. 8A) showed that E4
transcripts were not only expressed in epididymis but also in placenta
and Rat-1 cells (Fig. 8B). In vitro translation
of the E4 transcript generated a smaller protein (Pem-E) than that
translated from a normally spliced Pem transcript (Fig.
8C). Pem-E shares the first 26 amino acids of the amino
terminus with the known Pem protein but contains 55 novel amino acids
in the carboxyl terminus (Fig. 8D). Thus, Pem-E would lack the
homeodomain (present in the carboxyl region of Pem) but
would contain instead the most highly conserved region of the Pem
protein that is present in the amino terminus (35).
Fig. 8.
An exon-skipped transcript encodes a novel
form of Pem protein. A, schematic diagram showing the region
encompassed by probe J and the regions of the probe protected by RNA
from different cellular sources. B, RNase protection
analysis using probe J and total cellular RNA from epididymis (7 µg),
placenta (5 µg), Rat-1 cells (3 µg), or tRNA (20 µg).
C, SDS-polyacrylamide gel electrophoresis analysis of
reticulocyte lysate-translated Pem and Pem-E protein using in
vitro synthesized RNA containing the Pem and Pem-E reading frames
as templates. D, predicted amino acid sequence of Pem-E
encoded by the E4 transcript. Amino acids 1-26 are in common with
the Pem amino-terminal domain, Gly-27 is encoded by a codon across
the exon 3/5 junction, and amino acids 28-81 are novel amino acids
encoded by a different reading frame in exons 5 and 6.
Translational Regulation by Alternative 5 -UT Regions
We
compared the translatability of three alternatively spliced
Pem transcripts that differed only in their 5 -UT region: 1)
A-transcript; 2) M-transcript expressed exclusively in muscle; and 3)
T-transcript expressed exclusively in testis and epididymis. The three
different RNAs were generated in vitro and quantitated by
both optical density and by visual inspection of 2-fold serial
dilutions in agarose gels, and then equal amounts of the RNAs were
translated in vitro using reticulocyte lysates. Multiple
experiments with independent RNA samples demonstrated that T-transcript
was translated less efficiently than A-transcript (4-fold lower average
translation rate; Fig. 9). M-transcript was also
translated less efficiently than A-transcript, although the average
reduction was only 2-fold. We conclude that unique sequences present in
the 5 -UT regions of these three Pem transcripts can
alter the rate of translation in vitro.
Fig. 9.
Translational efficiency of Pem
transcripts possessing different 5 -UT termini. A,
schematic diagram depicting how the different 5 -UT termini on A-, M-,
and T-transcripts are generated in vivo. B,
SDS-polyacrylamide gel electrophoresis analysis of Pem
protein translated in vitro using reticulocyte lysates and
equal amounts of A-, M-, and T-transcripts generated in
vitro that differed only in their 5 termini.
DISCUSSION
In this report, we characterized the genomic structure of the
Pem gene, defined two promoters used in a tissue-specific
manner, and demonstrated that Pem transcripts undergo
alternative RNA splicing events. We showed that an
androgen-dependent promoter, Pp, is used
exclusively in male reproductive tissue, while the other promoter,
Pd, is expressed in female reproductive tissue and at low
levels in skeletal muscle (Fig. 2). We found that several different
modes of splicing regulation are exerted on Pem transcripts:
1) alternative exon inclusion; 2) alternative exon skipping; and 3)
alternative splice acceptor usage (Fig. 2).
We showed that mRNAs transcribed from the Pp
(T-transcripts) require androgens for expression (Fig. 4), which is
likely to explain why the Pp promoter is active in testis
and epididymis, and is not used detectably in placenta, muscle, or
ovary. The temporal pattern of T-transcript expression during
development differed in testis and epididymis. In prepubertal animals,
T-transcript levels were very high in epididymis but low in testis.
T-transcript levels were high as early as day 23 post partum
in epididymis, while in testis T-transcripts remained barely detectable
until day 44 and only reached levels similar to that of
Pd-derived transcripts at later developmental times (Fig.
5). The explanation for why T-transcripts are regulated differently in
testis and epididymis is not known. Since we showed that T-transcript
expression in epididymis requires testosterone, it is likely that the
early postnatal expression of this transcript in epididymis is due to
the known presence of androgens in the lumen of the epididymis at this
developmental time point (37, 38). Less clear is why T-transcript
levels are so low in testis. Expression of T-transcripts in the testis
in vivo requires testosterone, based on experiments in
EDS-treated rats,2 but the available
androgens in the testis may be insufficient to trigger strong
expression. Androgen-binding protein, which is secreted by Sertoli
cells and considered to act as an ``androgen sink'' in the testis and
as an androgen-carrier protein to the epididymis, is known to be
expressed at very high levels in rats (50-100-fold higher than in
mice; Ref. 39) and thus may depress Pp transcription in rat
testis. The specific androgens that are present in the testis at
different developmental time points may also influence Pem
expression. For example, the decline in the intratesticular levels of
5 -reductase after day 40 (40) would cause a switch in the ratio of
dihydrotestosterone to testosterone and thus may influence
transcription from the Pp.
The Pem gene is unusual in that it contains two promoter
regions and three 5 -UT exons upstream of the coding region. As a
result of alternative promoter usage and alternative splicing of these
5 -UT exons, Pem transcripts possess at least five different
5 termini (the number of variants is even greater if one considers the
multiple transcriptional initiation sites within both the
Pp and the Pd). Since the use of some of these
different 5 -UT sequences is regulated in a tissue- or
androgen-dependent manner, it is tempting to speculate that
they function in a regulatory capacity. We tested the effect of
different Pem 5 -UT termini on translatability in
vitro (Fig. 9) and found that Pem transcripts from the
Pp (T-transcripts) were translated less efficiently than
transcripts from the Pd (A-transcripts). Perhaps the male
reproductive cell types that express Pp-derived transcripts
down-regulate the level of Pem protein that is translated because
deleterious effects would be caused by Pem protein overexpression. In
skeletal muscle, a unique 5 -UT exon (the M exon) is included in
Pem transcripts that is excluded in all other tissues (Fig.
7). We found that inclusion of the M exon depressed translation
somewhat (Fig. 9), but since the effect was not dramatic, the M exon
may regulate events other than translation. For example, it is known
that 5 -UT sequences can regulate mRNA stability (45). It will be
of interest to determine if the M exon plays a role in the dramatic
induction of Pem transcripts in 10T1/2 mesenchymal
stem cells when they commit to the muscle cell lineage (22). Secondary
structure analysis by computer suggested that the different 5 termini
present in A-, M-, and T-transcripts possess different secondary
structures that may be responsible for the different rates of
translation.3 Tissue-specific factors may
be present in vivo that differentially bind to these
secondary structure regions and thereby regulate the translation rate
of Pem mRNAs that possess these different 5 termini.
Although many studies have demonstrated that translation is highly
regulated in germ cells (46, 47), little is known about translational
regulation in somatic cells of the testis and epididymis, where
Pem transcripts are
expressed.4
We identified an alternatively spliced transcript ( E4) that encodes
a novel form of the Pem protein (Pem-E). Many transcription factors,
including homeobox transcription factors, are known to be expressed as
multiple isoforms as a result of tissue-specific alternative RNA
splicing (41). Pem-E shares the amino terminus with the classical Pem
protein but lacks the homeodomain and thus may not bind DNA. Since the
amino-terminal region of Pem is, by far, the most conserved region of
this protein based on comparison of the primary amino acid sequence of
mouse and rat Pem (35), this region may possess functional
attributes. For example, the amino-terminal region may serve as a
binding interface that permits Pem and Pem-E to bind other proteins.
Many homeobox proteins have been shown to use amino acids outside of
the homeodomain to interact with other transcription factors, including
other homeobox proteins (9, 42, 43). The importance of regions outside
of the homeodomain for biological function is underscored by a recent
study showing that a mutant Ftz protein completely lacking the
homeodomain correctly regulates downstream target genes in
vivo, probably because it is still able to bind to other
transcription factors (44). Pem-E may act as an inhibitor protein that
competes with classical Pem for interaction with another transcription
factor, but by virtue of its inability to bind to DNA, it would exert a
dominant negative effect. By analogy, the Id inhibitor protein
possesses a helix-loop-helix motif and thus can dimerize with other
helix-loop-helix proteins, such as myoD, but because Id
lacks a DNA-binding domain it prevents these interacting
helix-loop-helix proteins from activating the transcription of
downstream target genes (41).
Most known examples of alternative transcriptional and
posttranscriptional events in male reproductive tissue are known to
occur in the germ cells (47). For example, the c-mos,
c-abl, pim-1, cytochrome c, cyclin D3,
superoxide dismutase, hoxa-4, proopiomelanocortin, and
SRY genes use alternative promoters in germ cells of the
testis that differ from the promoters used in somatic cells (48, 49, 50, 51, 52, 53, 54, 55).
One hypothesis to explain the common usage of alternative promoters in
germ cells is that it results from the changes in the chromatin
structure needed to produce spermatozoa. This restructuring would
not occur in somatic cells of the testis and epididymis, and
thus transcriptional regulation unique to these tissues is not
necessarily expected. The Pem gene is expressed by somatic
cells of the testis and epididymis,4 and thus it will be of
interest to determine how and why it is regulated in such a complex
manner at both the transcriptional and post-transcriptional level.
Since the Pem gene encodes a homeodomain-containing protein,
it is reasonable to suppose that the Pem protein is a transcription
factor that regulates specific events during male gametogenesis. The
finding that the Pem gene depends on androgen for expression
in the epididymis suggests that, in turn, Pem may regulate
androgen-dependent events in the epididymis. To our
knowledge no transcription factors have previously been shown to be
androgen-regulated in the epididymis. The homeobox transcription
factor, Pax-2, is clearly regulated by a distinct mechanism,
since it is expressed in the epididymis of tfm mice, which
lack androgen receptors (18). Several candidate downstream genes are
known to require androgens for expression in the epididymis (directly
or indirectly) and thus may be regulated by Pem, including
those encoding 5 -reductase, carboxypeptidase metalloprotein D/E
(AEG, CRISP-1), the retinol binding protein B/C (ESPI), the glutathione
peroxidase-like protein GPX, the glutamyltranspeptidase GGT, nerve
growth factor, and E-cadherin (7, 8). The epididymis has multiple
functions, many of which depend on the presence of androgens and thus
may be regulated by Pem: (i) induction of spermatozoa
motility capability, (ii) spermatozoa membrane alterations that permit
fertilization competence, (iii) changes in the methylation status of
spermatozoa genes, and (iv) spermatozoa storage (6, 7, 8, 56). Since the
Pem gene is specifically expressed in the distal
corpus/proximal cauda portion of the epididymis,4 the site
where spermatozoa gain motility capability and membrane alterations
necessary for fertilization competence (57, 58), it will be of interest
to determine whether Pem regulates these final maturation
events.
FOOTNOTES
*
This work was supported by National Institutes of Health
Grants HD 27233 and T32 EY07123. The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
``advertisement'' in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The nucleotide sequence(s) reported in this paper has been submitted to the GenBankTM/EMBL Data Bank with accession number(s) U52034[GenBank].
§
To whom correspondence should be addressed: U.T. M.D. Anderson
Cancer Center, Dept. of Immunology, Box 180, 1515 Holcombe Blvd.,
Houston, TX 77030. Tel.: 713-794-5526; Fax: 713-745-0846; E-mail:
Miles_Wilkinson{at}isqm.mda.uth.tmc.edu.
1
The abbreviations used are: UT, untranslated;
Pd, distal promoter; Pp, proximal promoter;
PCR, polymerase chain reaction; RT-PCR, reverse transcriptase-PCR; 5
RACE, 5 rapid amplification of cDNA ends; nt, nucleotide(s);
Tricine,
N-[2-hydroxy-1,1-bis(hydroxymethyl)ethyl]glycine;
PIPES, 1,4-piperazinediethanesulfonic acid; DHT,
dihydrotestosterone.
2
S. Maiti, M. Griswold, and M. F. Wilkinson,
unpublished observations.
3
J. Doskow and M. F. Wilkinson, unpublished
observations.
4
J. S. Lindsey and M. F. Wilkinson, submitted for
publication.
Acknowledgments
We express gratitude to Drs. Thomas Cooper,
Gail Cornwall, Gilbert Cote, Michael Griswold, Marvin Meistrich, and
Walter Tribley for critical reading of the manuscript.
REFERENCES
-
Santulli, R.,
Sprando, R. L.,
Awoniyi, C. A.,
Ewing, L. L.,
Zirken, B. R.
(1990)
Endocrinology
126,
95-101
[Abstract/Free Full Text]
-
Sun, Y.,
Wreford, N. G.,
Robertson, D. M.,
de Kretser, D. M.
(1990)
Endocrinology
127,
1215-1223
[Abstract/Free Full Text]
-
Singh, J.,
O'Neill, C.,
Handelsman, D. J.
(1995)
Endocrinology
136,
5311-5321
[Abstract]
-
Sar, M.,
Hall, S. H.,
Wilson, E. M.,
French, F. S.
(1993)
The Sertoli Cell
(Russell, L. D.,
Griswold, M. D.,
eds)
, p. 510, Cache River Press, Clearwater, FL
-
Norton, J. N.,
Skinner, M. K.
(1989)
Endocrinology
124,
2711-2719
[Abstract/Free Full Text]
-
Robarie, B.,
Hermo, L.
(1988)
The Physiology of Reproduction
(Knobil, E.,
Neill, J.,
eds)
, p. 999, Raven
Press, New York
-
Orgebin-Crist, M.-C. (1996) in Pharmacology, Biology, and
Clinical Applications of Androgens, (Bhasin, S., and Swevdloff, R. S., eds), Wiley-Liss, Inc., NY, in press
-
Cornwall, G.,
Hann, S. R.
(1995)
J. Androl.
16,
379-383
[Free Full Text]
-
Duboule, D.
(1994)
Guidebook to the Homeobox Genes
, Oxford
University Press, Oxford
-
Gruss, P.,
Walther, C.
(1992)
Cell
69,
719-722
[CrossRef][Medline]
[Order article via Infotrieve]
-
Corcoran, L. M.,
Karvelas, M.,
Nossal, G. J. V.,
Ye, Z.-S.,
Jacks, T.,
Baltimore, D.
(1993)
Genes Dev.
7,
570-582
[Abstract/Free Full Text]
-
Krumlauf, R.
(1994)
Cell
78,
191-201
[CrossRef][Medline]
[Order article via Infotrieve]
-
Andersen, B.,
Pearse, R. V., II,
Schlegel, P. N.,
Cichon, Z.,
Schonemann, M. D.,
Bardin, C. W.,
Rosenfeld, M. G.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
11084-11088
[Abstract/Free Full Text]
-
Wolgemuth, D. J.,
Viviano, C. M.,
Watrin, F.
(1991)
Ann. N. Y. Acad. Sci.
637,
300-312
[Medline]
[Order article via Infotrieve]
-
Watrin, F.,
Wolgemuth, D. J.
(1993)
Dev. Biol.
156,
136-145
[CrossRef][Medline]
[Order article via Infotrieve]
-
Featherstone, M. S.,
Baron, A.,
Gaunt, S.,
Mattei, M. G.,
Duboule, D.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
4760-4764
[Abstract/Free Full Text]
-
Graham, A.,
Papalopulu, N.,
Lorimer, J.,
McVey, J. H.,
Tuddenham, E. G. D.,
Krumlauf, R.
(1988)
Genes Dev.
2,
1424-1438
[Abstract/Free Full Text]
-
Fickenscher, H. R.,
Chalepakis, G.,
Gruss, P.
(1993)
DNA Cell Biol.
5,
381-391
-
Xin, J.-H.,
Cowie, A.,
Lachance, P.,
Hassell, J. A.
(1992)
Genes Dev.
6,
481-496
[Abstract/Free Full Text]
-
MacLeod, C. L.,
Fong, A. M.,
Seal, B. S.,
Walls, L.,
Wilkinson, M.
F.
(1990)
Cell Growth & Differ.
1,
271-279
[Abstract]
-
Wilkinson, M. F.,
Kleeman, J.,
Richards, J.,
MacLeod, C. L.
(1990)
Dev. Biol.
141,
451-455
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sasaki, A. W.,
Doskow, J.,
MacLeod, C. L.,
Rogers, M. B.,
Gudas, L. J.,
Wilkinson, M. F.
(1991)
Mech. Dev.
34,
155-164
[CrossRef][Medline]
[Order article via Infotrieve]
-
Rayle, R. E.
(1991)
Dev. Biol.
146,
255-257
[CrossRef][Medline]
[Order article via Infotrieve]
-
Lin, T.-P.,
Labosky, P. A.,
Grabel, L. B.,
Kozak, C. A.,
Pitman, J. L.,
Kleeman, J.,
MacLeod, C. L.
(1994)
Dev. Biol.
166,
170-179
[CrossRef][Medline]
[Order article via Infotrieve]
-
Labosky, P. A.,
Weir, M. P.,
Grabel, L. B.
(1993)
Dev. Biol.
159,
232-244
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sambrook, J.,
Fritsch, E. F.,
Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, Cold Spring Harbor Laboratory, Cold
Spring Harbor, NY
-
Siebert, P. D.,
Chenchik, A.,
Kellog, D. E.,
Lukyanov, K. A.,
Lukyanov, S. A.
(1985)
Nucleic Acids Res.
23,
1087-1088
[Free Full Text]
-
Wilkinson, M. F.
(1991)
Essential Molecular Biology: A Practical Approach
(Brown, T. A.,
eds)
, p. 69, Oxford
University Press, New York
-
Chomczynski, P.,
Sacchi, N.
(1987)
Anal. Biochem.
162,
156-159
[Medline]
[Order article via Infotrieve]
-
Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Smith, J. A.,
Seidman, J. G., and Struhl, K. (1987) Current Protocols in
Molecular Biology, sections 3.8 and 4.7, John Wiley & Sons, Inc.,
New York
-
McKnight, S. L.,
Gavis, E. R.,
Kingsbury, R. C.,
Axel, R.
(1981)
Cell
25,
385-398
[CrossRef][Medline]
[Order article via Infotrieve]
-
Qian, L.,
Vu, M. N.,
Carter, M. S.,
Doskow, J.,
Wilkinson, M. F.
(1993)
J. Immunol.
151,
6801-6814
[Abstract]
-
Resko, J. A.,
Ellinwood, W. E.,
Pasztor, L. M.,
Buhl, A. E.
(1980)
J. Clin. Endocrinol. & Metab.
50,
900-905
[Abstract/Free Full Text]
-
Schneitz, K.,
Spielmann, P.,
Noll, M.
(1993)
Genes Dev.
7,
114-129
[Abstract/Free Full Text]
-
Maiti, S., Doskow, J., Sutton, K., Nhim, R. P., Lawlor, D. A., Levan,
K., Lindsey, J. S., and Wilkinson, M. F. (1996) Genomics, in
press
-
Kozak, M.
(1991)
J. Cell Biol.
115,
887-903
[Abstract/Free Full Text]
-
Tindall, D. J., Vitale, R., and Means, A. R. (1975) Endocrinology
97 636-648
[Abstract/Free Full Text]
-
Charest, N. J.,
Petrusz, P.,
Ordronneau, P.,
Joseph, D. R.,
Wilson, E.
M.,
French, F. S.
(1989)
Endocrinology
125,
942-947
[Abstract/Free Full Text]
-
Wang, Y.-M.,
Sullivan, P. M.,
Petrusz, P.,
Yarbrough, W.,
Joseph, D. R.
(1989)
Mol. Cell. Endocrinol.
63,
85-92
[CrossRef][Medline]
[Order article via Infotrieve]
-
Preslock, J. P. (1980) Endocrinol. Rev. 1, 132-139
[Abstract/Free Full Text]
-
López, A. J.
(1995)
Dev. Biol.
172,
396-411
[CrossRef][Medline]
[Order article via Infotrieve]
-
Vershon, A. K.,
Jin, Y.,
Johnson, A. D.
(1995)
Genes Dev.
9,
182-192
[Abstract/Free Full Text]
-
Kämper, J.,
Reichmann, M.,
Romeis, T.,
Bölker, M.,
Kahmann, R.
(1995)
Cell
81,
73-83
[CrossRef][Medline]
[Order article via Infotrieve]
-
Copeland, J. W. R.,
Nasiadka, A.,
Dietrich, B. H.,
Krause, H. M.
(1996)
Nature
379,
162-164
[CrossRef][Medline]
[Order article via Infotrieve]
-
Peltz, S. W.,
Brewer, G.,
Bernstein, P.,
Hart, P. A.,
Ross, J.
(1991)
Crit. Rev. Eukaryotic Gene Expr.
1,
99-126
[Medline]
[Order article via Infotrieve]
-
Schäfer, M.,
Nayernia, K.,
Engel, W.,
Schäfer, U.
(1995)
Dev. Biol.
172,
344-352
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hecht, N. B.
(1995)
Dev. Genet.
16,
95-103
[CrossRef][Medline]
[Order article via Infotrieve]
-
Sorrentino, V.,
McKinney, M. D.,
Giorgi, M.,
Geremia, R.,
Fleissner, E.
(1988)
Proc. Natl. Acad. Sci. U. S. A.
85,
2191-2195
[Abstract/Free Full Text]
-
Ito, E.,
Toki, T.,
Ishihara, H.,
Ohtani, H.,
Gu, L.,
Yokoyama, M.,
Engel, J. D.,
Yamamoto, M.
(1993)
Nature
362,
466-468
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hake, L. E.,
Hecht, N. B.
(1993)
J. Biol. Chem.
268,
4788-4797
[Abstract/Free Full Text]
-
Yiu, G. Y.,
Gu, W.,
Hecht, N. B.
(1994)
Nucleic Acids Res.
22,
4599-4606
[Abstract/Free Full Text]
-
Gu, W.,
Morales, C.,
Hecht, N. B.
(1995)
J. Biol. Chem.
270,
236-243
-
Ravnik, S. E.,
Rhee, K.,
Wolgemuth, D. J.
(1995)
Dev. Genet.
16,
171-178
[CrossRef][Medline]
[Order article via Infotrieve]
-
Hacker, A.,
Capel, B.,
Goodfellow, P.,
Lovell-Badge, R.
(1995)
Development
121,
1603-1614
[Abstract]
-
Propst, F.,
Rosenberg, M. P.,
Vande Woude, G. F.
(1988)
Trends Genet.
4,
183-187
[CrossRef][Medline]
[Order article via Infotrieve]
-
Ariel, M.,
Cedar, H.,
McCarrey, J.
(1994)
Nat. Genet.
7,
59-63
[CrossRef][Medline]
[Order article via Infotrieve]
-
Blaquier, J. A.,
Cameo, M. S.,
Cuasnicu, P. S.,
Gonzalez Echeverria, M.
F.,
Piñeiro, L.,
Tezon, J. G.
(1988)
Ann. N. Y. Acad. Sci.
541,
292-296
[Medline]
[Order article via Infotrieve]
-
Moore, H. D. M.,
Hartman, T. D.,
Smith, C. A.
(1986)
J. Reprod. Fertil.
78,
327-336
[Abstract/Free Full Text]
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R P Hooley, M Paterson, P Brown, K Kerr, and P T K Saunders
Intra-testicular injection of adenoviral constructs results in Sertoli cell-specific gene expression and disruption of the seminiferous epithelium
Reproduction,
February 1, 2009;
137(2):
361 - 370.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Prabagaran, A.H. Bandivdekar, V. Dighe, and V.P. Raghavan
HOXBES2: A Novel Epididymal HOXB2 Homeoprotein and Its Domain-Specific Association with Spermatozoa
Biol Reprod,
February 1, 2007;
76(2):
314 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. A. MacLean II, M. K. Rao, K. M.H. Doyle, J. S. Richards, and M. F. Wilkinson
Regulation of the Rhox5 Homeobox Gene in Primary Granulosa Cells: Preovulatory Expression and Dependence on SP1/SP3 and GABP
Biol Reprod,
December 1, 2005;
73(6):
1126 - 1134.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Jansen, J. S. E. Laven, H. B. R. Dommerholt, J. Polman, C. van Rijt, C. van den Hurk, J. Westland, S. Mosselman, and B. C. J. M. Fauser
Abnormal Gene Expression Profiles in Human Ovaries from Polycystic Ovary Syndrome Patients
Mol. Endocrinol.,
December 1, 2004;
18(12):
3050 - 3063.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y.-L. Kang, H. Li, W.-H. Chen, Y.-S. Tzeng, Y.-L. Lai, and H. M. Hsieh-Li
A Novel PEPP Homeobox Gene, TOX, Is Highly Glutamic Acid Rich and Specifically Expressed in Murine Testis and Ovary
Biol Reprod,
March 1, 2004;
70(3):
828 - 836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. I. Sadate-Ngatchou, D. J. Pouchnik, and M. D. Griswold
Identification of Testosterone-Regulated Genes in Testes of Hypogonadal Mice Using Oligonucleotide Microarray
Mol. Endocrinol.,
February 1, 2004;
18(2):
422 - 433.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Rao, C. M. Wayne, M. L. Meistrich, and M. F. Wilkinson
Pem Homeobox Gene Promoter Sequences that Direct Transcription in a Sertoli Cell-Specific, Stage-Specific, and Androgen-Dependent Manner in the Testis in Vivo
Mol. Endocrinol.,
February 1, 2003;
17(2):
223 - 233.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Rao, C. M. Wayne, and M. F. Wilkinson
Pem Homeobox Gene Regulatory Sequences That Direct Androgen-dependent Developmentally Regulated Gene Expression in Different Subregions of the Epididymis
J. Biol. Chem.,
December 6, 2002;
277(50):
48771 - 48778.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Wayne, K. Sutton, and M. F. Wilkinson
Expression of the Pem Homeobox Gene in Sertoli Cells Increases the Frequency of Adjacent Germ Cells with Deoxyribonucleic Acid Strand Breaks
Endocrinology,
December 1, 2002;
143(12):
4875 - 4885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K. Rao, S. Maiti, H. N. Ananthaswamy, and M. F. Wilkinson
A Highly Active Homeobox Gene Promoter Regulated by Ets and Sp1 Family Members in Normal Granulosa Cells and Diverse Tumor Cell Types
J. Biol. Chem.,
July 12, 2002;
277(29):
26036 - 26045.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Nixon, C. M. Hardy, R. C. Jones, J. B. Andrews, and M. K. Holland
Rabbit Epididymal Secretory Proteins. III. Molecular Cloning and Characterization of the Complementary DNA for REP38
Biol Reprod,
July 1, 2002;
67(1):
147 - 153.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Eriksson, V. Tohonen, A. Wedell, and K. Nordqvist
Isolation of the human testatin gene and analysis in patients with abnormal gonadal development
Mol. Hum. Reprod.,
January 1, 2002;
8(1):
8 - 15.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Barbulescu, C. Geserick, I. Schuttke, W.-D. Schleuning, and B. Haendler
New Androgen Response Elements in the Murine Pem Promoter Mediate Selective Transactivation
Mol. Endocrinol.,
October 1, 2001;
15(10):
1803 - 1816.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Maiti, M. L. Meistrich, G. Wilson, G. Shetty, M. Marcelli, M. J. McPhaul, P. L. Morris, and M. F. Wilkinson
Irradiation Selectively Inhibits Expression from the Androgen-Dependent Pem Homeobox Gene Promoter in Sertoli Cells
Endocrinology,
April 1, 2001;
142(4):
1567 - 1577.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. G. Hamil, P. Sivashanmugam, R. T. Richardson, G. Grossman, S. M. Ruben, J. L. Mohler, P. Petrusz, M. G. O'Rand, F. S. French, and S. H. Hall
HE2{beta} and HE2{gamma}, New Members of an Epididymis-Specific Family of Androgen-Regulated Proteins in the Human
Endocrinology,
March 1, 2000;
141(3):
1245 - 1253.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. G. Sheflin and S. W. Spaulding
Testosterone and dihydrotestosterone regulate AUF1 isoforms in a tissue-specific fashion in the mouse
Am J Physiol Endocrinol Metab,
January 1, 2000;
278(1):
E50 - E57.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Misteli, J. F. Caceres, J. Q. Clement, A. R. Krainer, M. F. Wilkinson, and D. L. Spector
Serine Phosphorylation of SR Proteins Is Required for Their Recruitment to Sites of Transcription In Vivo
J. Cell Biol.,
October 19, 1998;
143(2):
297 - 307.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. J. Whiting, G. McAllister, D. Vassilatis, T. P. Bonnert, R. P. Heavens, D. W. Smith, L. Hewson, R. O'Donnell, M. R. Rigby, D. J. S. Sirinathsinghji, et al.
Neuronally Restricted RNA Splicing Regulates the Expression of a Novel GABAA Receptor Subunit Conferring Atypical Functional Properties
J. Neurosci.,
July 1, 1997;
17(13):
5027 - 5037.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. V. Barnes, G. Cheng, M. M. Dawson, and D. R. Menick
Cloning of Cardiac, Kidney, and Brain Promoters of the Feline ncx1 Gene
J. Biol. Chem.,
April 25, 1997;
272(17):
11510 - 11517.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Q. Clement, S. Maiti, and M. F. Wilkinson
Localization and Stability of Introns Spliced from the Pem Homeobox Gene
J. Biol. Chem.,
May 11, 2001;
276(20):
16919 - 16930.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|